Cargando…
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
OBJECTIVES: To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition. METHODS: 1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Disco...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288789/ https://www.ncbi.nlm.nih.gov/pubmed/30464029 http://dx.doi.org/10.1136/jnnp-2018-318337 |
_version_ | 1783379859924320256 |
---|---|
author | Lawton, Michael Ben-Shlomo, Yoav May, Margaret T Baig, Fahd Barber, Thomas R Klein, Johannes C Swallow, Diane M A Malek, Naveed Grosset, Katherine A Bajaj, Nin Barker, Roger A Williams, Nigel Burn, David J Foltynie, Thomas Morris, Huw R Wood, Nicholas W Grosset, Donald G Hu, Michele T M |
author_facet | Lawton, Michael Ben-Shlomo, Yoav May, Margaret T Baig, Fahd Barber, Thomas R Klein, Johannes C Swallow, Diane M A Malek, Naveed Grosset, Katherine A Bajaj, Nin Barker, Roger A Williams, Nigel Burn, David J Foltynie, Thomas Morris, Huw R Wood, Nicholas W Grosset, Donald G Hu, Michele T M |
author_sort | Lawton, Michael |
collection | PubMed |
description | OBJECTIVES: To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition. METHODS: 1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Discovery cohorts, respectively, were evaluated in motor, cognitive and non-motor domains at the baseline assessment. Patients were recently diagnosed at entry (within 3.5 years of diagnosis) and were followed up every 18 months. We used a factor analysis followed by a k-means cluster analysis, while prognosis was measured using random slope and intercept models. RESULTS: We identified four clusters: (1) fast motor progression with symmetrical motor disease, poor olfaction, cognition and postural hypotension; (2) mild motor and non-motor disease with intermediate motor progression; (3) severe motor disease, poor psychological well-being and poor sleep with an intermediate motor progression; (4) slow motor progression with tremor-dominant, unilateral disease. Clusters were moderately to substantially stable across the two cohorts (kappa 0.58). Cluster 1 had the fastest motor progression in Tracking Parkinson’s at 3.2 (95% CI 2.8 to 3.6) UPDRS III points per year while cluster 4 had the slowest at 0.6 (0.1–1.1). In Tracking Parkinson’s, cluster 2 had the largest response to levodopa 36.3% and cluster 4 the lowest 28.8%. CONCLUSIONS: We have found four novel clusters that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates. This has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials. |
format | Online Article Text |
id | pubmed-6288789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-62887892018-12-27 Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression Lawton, Michael Ben-Shlomo, Yoav May, Margaret T Baig, Fahd Barber, Thomas R Klein, Johannes C Swallow, Diane M A Malek, Naveed Grosset, Katherine A Bajaj, Nin Barker, Roger A Williams, Nigel Burn, David J Foltynie, Thomas Morris, Huw R Wood, Nicholas W Grosset, Donald G Hu, Michele T M J Neurol Neurosurg Psychiatry Movement Disorders OBJECTIVES: To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition. METHODS: 1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Discovery cohorts, respectively, were evaluated in motor, cognitive and non-motor domains at the baseline assessment. Patients were recently diagnosed at entry (within 3.5 years of diagnosis) and were followed up every 18 months. We used a factor analysis followed by a k-means cluster analysis, while prognosis was measured using random slope and intercept models. RESULTS: We identified four clusters: (1) fast motor progression with symmetrical motor disease, poor olfaction, cognition and postural hypotension; (2) mild motor and non-motor disease with intermediate motor progression; (3) severe motor disease, poor psychological well-being and poor sleep with an intermediate motor progression; (4) slow motor progression with tremor-dominant, unilateral disease. Clusters were moderately to substantially stable across the two cohorts (kappa 0.58). Cluster 1 had the fastest motor progression in Tracking Parkinson’s at 3.2 (95% CI 2.8 to 3.6) UPDRS III points per year while cluster 4 had the slowest at 0.6 (0.1–1.1). In Tracking Parkinson’s, cluster 2 had the largest response to levodopa 36.3% and cluster 4 the lowest 28.8%. CONCLUSIONS: We have found four novel clusters that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates. This has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials. BMJ Publishing Group 2018-12 2018-07-25 /pmc/articles/PMC6288789/ /pubmed/30464029 http://dx.doi.org/10.1136/jnnp-2018-318337 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ. This is an Open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Movement Disorders Lawton, Michael Ben-Shlomo, Yoav May, Margaret T Baig, Fahd Barber, Thomas R Klein, Johannes C Swallow, Diane M A Malek, Naveed Grosset, Katherine A Bajaj, Nin Barker, Roger A Williams, Nigel Burn, David J Foltynie, Thomas Morris, Huw R Wood, Nicholas W Grosset, Donald G Hu, Michele T M Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression |
title | Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression |
title_full | Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression |
title_fullStr | Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression |
title_full_unstemmed | Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression |
title_short | Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression |
title_sort | developing and validating parkinson’s disease subtypes and their motor and cognitive progression |
topic | Movement Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288789/ https://www.ncbi.nlm.nih.gov/pubmed/30464029 http://dx.doi.org/10.1136/jnnp-2018-318337 |
work_keys_str_mv | AT lawtonmichael developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT benshlomoyoav developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT maymargarett developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT baigfahd developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT barberthomasr developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT kleinjohannesc developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT swallowdianema developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT maleknaveed developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT grossetkatherinea developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT bajajnin developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT barkerrogera developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT williamsnigel developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT burndavidj developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT foltyniethomas developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT morrishuwr developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT woodnicholasw developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT grossetdonaldg developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression AT humicheletm developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression |